Veradermics, Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for skin diseases. The company's primary focus is on addressing significant unmet medical needs in the treatment of viral skin infections, such as molluscum contagiosum and common warts. Veradermics' lead product candidate, VD-101, is a proprietary, stable, and standardized topical formulation of cantharidin. This candidate is being developed for the treatment of molluscum contagiosum, a common and highly contagious viral skin infection that primarily affects children and currently lacks widely approved, painless, and effective treatments. The company's approach combines specialized drug delivery technology with established active pharmaceutical ingredients to improve safety, efficacy, and the overall patient experience. By targeting pediatric and adult populations suffering from contagious skin conditions, Veradermics aims to capture a significant share of the dermatology market. The company is led by a management team with extensive experience in clinical development and regulatory pathways within the pharmaceutical sector, focusing on advancing its clinical programs to bring therapeutic solutions to the global market.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!